{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lisinopril : Questions médicales les plus fréquentes",
"headline": "Lisinopril : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lisinopril : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-01",
"dateModified": "2024-12-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lisinopril"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Dipeptides",
"url": "https://recherchemedicale.com/mesh/D004151",
"about": {
"@type": "MedicalCondition",
"name": "Dipeptides",
"code": {
"@type": "MedicalCode",
"code": "D004151",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.644.456.345"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Lisinopril",
"alternateName": "Lisinopril",
"code": {
"@type": "MedicalCode",
"code": "D017706",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Meetha Medhora",
"url": "https://recherchemedicale.com/author/Meetha%20Medhora",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiation Oncology, Medical College of WI, Milwaukee, WI, United States."
}
},
{
"@type": "Person",
"name": "Jayashree Narayanan",
"url": "https://recherchemedicale.com/author/Jayashree%20Narayanan",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiation Oncology, Medical College of WI, Milwaukee, WI, United States."
}
},
{
"@type": "Person",
"name": "Tracy Gasperetti",
"url": "https://recherchemedicale.com/author/Tracy%20Gasperetti",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiation Oncology, Medical College of WI, Milwaukee, WI, United States."
}
},
{
"@type": "Person",
"name": "Brian L Fish",
"url": "https://recherchemedicale.com/author/Brian%20L%20Fish",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiation Oncology, Medical College of WI, Milwaukee, WI, United States."
}
},
{
"@type": "Person",
"name": "Feng Gao",
"url": "https://recherchemedicale.com/author/Feng%20Gao",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Response to Lisinopril in Patients with Sickle Cell Anemia and Proteinuria.",
"datePublished": "2024-05-09",
"url": "https://recherchemedicale.com/article/38725203",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4103/sjkdt.sjkdt_312_22"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lisinopril prevents bullous pemphigoid induced by dipeptidyl peptidase 4 inhibitors",
"datePublished": "2023-01-05",
"url": "https://recherchemedicale.com/article/36685490",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.1084960"
}
},
{
"@type": "ScholarlyArticle",
"name": "Impact of Lisinopril on Cardiometabolic Risk Factors in Sisters of Women With Polycystic Ovary Syndrome.",
"datePublished": "2023-05-27",
"url": "https://recherchemedicale.com/article/37173821",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/jcph.2268"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lisinopril-Induced Small Bowel Angioedema: An Unusual Cause of Severe Abdominal Pain.",
"datePublished": "2022-11-22",
"url": "https://recherchemedicale.com/article/36413511",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.12659/AJCR.937895"
}
},
{
"@type": "ScholarlyArticle",
"name": "Oral combined hydrochlorothiazide and lisinopril vs nifedipine for postpartum hypertension: a comparative-effectiveness pilot randomized controlled trial.",
"datePublished": "2023-02-12",
"url": "https://recherchemedicale.com/article/36787814",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ajog.2023.01.015"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Recherchemedicale.com",
"item": "https://recherchemedicale.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://recherchemedicale.com/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Peptides",
"item": "https://recherchemedicale.com/mesh/D010455"
},
{
"@type": "ListItem",
"position": 4,
"name": "Oligopeptides",
"item": "https://recherchemedicale.com/mesh/D009842"
},
{
"@type": "ListItem",
"position": 5,
"name": "Dipeptides",
"item": "https://recherchemedicale.com/mesh/D004151"
},
{
"@type": "ListItem",
"position": 6,
"name": "Lisinopril",
"item": "https://recherchemedicale.com/mesh/D017706"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lisinopril - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lisinopril",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-01-23",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lisinopril",
"description": "Comment le lisinopril est-il prescrit ?\nQuels tests sont nécessaires avant de commencer le lisinopril ?\nLe lisinopril est-il utilisé pour le diagnostic ?\nQuels signes indiquent un besoin de lisinopril ?\nLe lisinopril est-il efficace pour tous les patients ?",
"url": "https://recherchemedicale.com/mesh/D017706#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lisinopril",
"description": "Quels symptômes le lisinopril aide-t-il à soulager ?\nQuels effets secondaires peuvent survenir avec le lisinopril ?\nLe lisinopril peut-il provoquer des symptômes allergiques ?\nQuels signes d'effets indésirables doivent alerter ?\nLe lisinopril peut-il causer des douleurs abdominales ?",
"url": "https://recherchemedicale.com/mesh/D017706#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lisinopril",
"description": "Le lisinopril peut-il prévenir des maladies cardiaques ?\nQuelles mesures doivent accompagner le traitement par lisinopril ?\nLe lisinopril est-il efficace pour prévenir l'hypertension ?\nDes changements de mode de vie sont-ils nécessaires avec le lisinopril ?\nLe lisinopril peut-il être utilisé en prévention primaire ?",
"url": "https://recherchemedicale.com/mesh/D017706#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lisinopril",
"description": "Comment le lisinopril est-il administré ?\nQuelle est la posologie habituelle du lisinopril ?\nLe lisinopril peut-il être combiné avec d'autres médicaments ?\nCombien de temps faut-il pour que le lisinopril agisse ?\nLe lisinopril nécessite-t-il un suivi médical ?",
"url": "https://recherchemedicale.com/mesh/D017706#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lisinopril",
"description": "Quelles complications peuvent survenir avec le lisinopril ?\nLe lisinopril peut-il causer des complications cardiovasculaires ?\nComment gérer les complications liées au lisinopril ?\nLe lisinopril peut-il interagir avec d'autres médicaments ?\nQuels signes indiquent une complication grave ?",
"url": "https://recherchemedicale.com/mesh/D017706#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lisinopril",
"description": "Quels facteurs augmentent le risque d'effets secondaires du lisinopril ?\nLe diabète est-il un facteur de risque pour le lisinopril ?\nL'hypertension est-elle un facteur de risque pour le lisinopril ?\nLe tabagisme influence-t-il l'efficacité du lisinopril ?\nQuels antécédents médicaux sont des facteurs de risque ?",
"url": "https://recherchemedicale.com/mesh/D017706#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment le lisinopril est-il prescrit ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le lisinopril est prescrit après évaluation de la pression artérielle et des antécédents médicaux."
}
},
{
"@type": "Question",
"name": "Quels tests sont nécessaires avant de commencer le lisinopril ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de fonction rénale et des électrolytes sont recommandés avant le traitement."
}
},
{
"@type": "Question",
"name": "Le lisinopril est-il utilisé pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, le lisinopril est un traitement, pas un outil de diagnostic."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un besoin de lisinopril ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une pression artérielle élevée ou des symptômes d'insuffisance cardiaque peuvent indiquer un besoin."
}
},
{
"@type": "Question",
"name": "Le lisinopril est-il efficace pour tous les patients ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Son efficacité peut varier selon les individus et les conditions médicales sous-jacentes."
}
},
{
"@type": "Question",
"name": "Quels symptômes le lisinopril aide-t-il à soulager ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il aide à réduire les symptômes liés à l'hypertension et à l'insuffisance cardiaque."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires peuvent survenir avec le lisinopril ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent la toux sèche, des vertiges et des troubles rénaux."
}
},
{
"@type": "Question",
"name": "Le lisinopril peut-il provoquer des symptômes allergiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réactions allergiques comme l'urticaire peuvent survenir chez certains patients."
}
},
{
"@type": "Question",
"name": "Quels signes d'effets indésirables doivent alerter ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des gonflements du visage, des difficultés respiratoires ou des éruptions cutanées doivent alerter."
}
},
{
"@type": "Question",
"name": "Le lisinopril peut-il causer des douleurs abdominales ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs abdominales peuvent être un effet secondaire rare du lisinopril."
}
},
{
"@type": "Question",
"name": "Le lisinopril peut-il prévenir des maladies cardiaques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut réduire le risque de maladies cardiaques chez les patients hypertendus."
}
},
{
"@type": "Question",
"name": "Quelles mesures doivent accompagner le traitement par lisinopril ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, est recommandé."
}
},
{
"@type": "Question",
"name": "Le lisinopril est-il efficace pour prévenir l'hypertension ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est utilisé pour traiter l'hypertension, mais ne prévient pas son apparition."
}
},
{
"@type": "Question",
"name": "Des changements de mode de vie sont-ils nécessaires avec le lisinopril ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des changements comme réduire le sel et arrêter de fumer sont souvent conseillés."
}
},
{
"@type": "Question",
"name": "Le lisinopril peut-il être utilisé en prévention primaire ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'est généralement pas utilisé en prévention primaire sans hypertension existante."
}
},
{
"@type": "Question",
"name": "Comment le lisinopril est-il administré ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le lisinopril est généralement pris par voie orale sous forme de comprimés."
}
},
{
"@type": "Question",
"name": "Quelle est la posologie habituelle du lisinopril ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La posologie initiale est souvent de 10 mg par jour, ajustée selon la réponse."
}
},
{
"@type": "Question",
"name": "Le lisinopril peut-il être combiné avec d'autres médicaments ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être combiné avec d'autres antihypertenseurs pour un meilleur contrôle."
}
},
{
"@type": "Question",
"name": "Combien de temps faut-il pour que le lisinopril agisse ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets peuvent être observés dans les heures suivant la prise, mais l'effet maximal prend plusieurs semaines."
}
},
{
"@type": "Question",
"name": "Le lisinopril nécessite-t-il un suivi médical ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est nécessaire pour surveiller la pression artérielle et la fonction rénale."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec le lisinopril ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme l'hyperkaliémie et des problèmes rénaux peuvent survenir."
}
},
{
"@type": "Question",
"name": "Le lisinopril peut-il causer des complications cardiovasculaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rarement, mais une hypotension sévère peut entraîner des complications cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées au lisinopril ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut l'ajustement de la dose ou l'arrêt du médicament sous supervision médicale."
}
},
{
"@type": "Question",
"name": "Le lisinopril peut-il interagir avec d'autres médicaments ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut interagir avec des diurétiques et des suppléments de potassium, augmentant les risques."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une complication grave ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des douleurs thoraciques, des évanouissements ou des gonflements doivent alerter."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'effets secondaires du lisinopril ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, les maladies rénales et la déshydratation augmentent le risque d'effets secondaires."
}
},
{
"@type": "Question",
"name": "Le diabète est-il un facteur de risque pour le lisinopril ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients diabétiques doivent être surveillés de près lors de l'utilisation du lisinopril."
}
},
{
"@type": "Question",
"name": "L'hypertension est-elle un facteur de risque pour le lisinopril ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, l'hypertension est la condition traitée par le lisinopril, pas un facteur de risque."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il l'efficacité du lisinopril ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut réduire l'efficacité du lisinopril et aggraver les problèmes cardiaques."
}
},
{
"@type": "Question",
"name": "Quels antécédents médicaux sont des facteurs de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents d'accidents vasculaires cérébraux ou de maladies cardiaques sont des facteurs de risque."
}
}
]
}
]
}
Department of Emergency Medicine, University of Colorado School of Medicine, Leprino Building, 7th Floor Campus Box B-215, 12401 E. 17th Avenue, Aurora, CO, 80045, USA.
Center for Bioinformatics & Personalized Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
Skaggs School of Pharmacy, University of Colorado, Aurora, CO, USA.
Department of Emergency Medicine, University of Colorado School of Medicine, Leprino Building, 7th Floor Campus Box B-215, 12401 E. 17th Avenue, Aurora, CO, 80045, USA. jessica.saben@cuanschutz.edu.
Emergency Department, University of Colorado - Anschutz Medical Campus, Building 400, Q09-127,12469 E 17th Pl, 80045, Aurora, CO, USA. jessica.saben@cuanschutz.edu.
Department of Emergency Medicine, University of Colorado School of Medicine, Leprino Building, 7th Floor Campus Box B-215, 12401 E. 17th Avenue, Aurora, CO, 80045, USA.
Department of Emergency Medicine, University of Colorado School of Medicine, Leprino Building, 7th Floor Campus Box B-215, 12401 E. 17th Avenue, Aurora, CO, 80045, USA.
Department of Emergency Medicine, University of Colorado School of Medicine, Leprino Building, 7th Floor Campus Box B-215, 12401 E. 17th Avenue, Aurora, CO, 80045, USA.
Center for Bioinformatics & Personalized Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
Skaggs School of Pharmacy, University of Colorado, Aurora, CO, USA.
Rocky Mountain Poison & Drug Center, Denver Health and Hospital Authority, Denver, CO, USA.
Proteinuria is a manifestation of sickle cell anemia (SCA)-related renal disease and is a risk factor of renal impairment. Angiotensin-converting enzyme (ACE) inhibitors have benefits, but their role ...
Recent studies have suggested that dipeptidyl peptidase 4 (DPP4) inhibitors increase the risk of development of bullous pemphigoid (BP), which is the most common autoimmune blistering skin disease; ho...
Women with polycystic ovary syndrome (PCOS), the most common endocrinopathy in reproductive age, are characterized by increased cardiometabolic risk. Similar hormonal and metabolic changes were found ...
BACKGROUND Angiotensin-converting enzyme inhibitors (ACE-I) are one of the most frequently prescribed classes of medications with the rare adverse effect of angioedema, and isolated small bowel angioe...
Angiotensin-converting enzyme inhibitors and diuretics may be underutilized for postpartum hypertension because of their teratogenicity during pregnancy....
We evaluated whether combined oral hydrochlorothiazide and lisinopril therapy produced superior short-term blood pressure control when compared with nifedipine among postpartum individuals with hypert...
We performed a pilot randomized controlled trial (October 2021 to June 2022) that included individuals with chronic hypertension or hypertensive disorders of pregnancy with 2 systolic blood pressure m...
Of 111 eligible individuals, 70 (63%) agreed and were randomized (31 in the hydrochlorothiazide and lisinopril group and 36 in the nifedipine group; 3 withdrew consent after randomization), and the ch...
The results of the pilot trial suggest a high probability that combined hydrochlorothiazide and lisinopril therapy produces superior short-term BP control when compared with nifedipine. These findings...
The combination of lisinopril and amlodipine has a marked additional effect on blood pressure and fewer side effects than individual monotherapy. This study was conducted to compare the pharmacokineti...
A single center, randomized, open-label, single-dose, two-period crossover bioequivalence study was designed in healthy Chinese subjects under both fasting and fed conditions. Blood samples were colle...
Ninety-two healthy subjects were enrolled, and 75 completed the study. The 90% confidence intervals (CIs) of the ratio of geometric means (GMRs) of C...
The trial demonstrated that the test and the reference lisinopril/amlodipine tablets were bioequivalent and well tolerated in Chinese people under fasting and fed conditions....
Clinical Trails.gov identifier, NCT04885660 (retrospectively registered in 13/05/ 2021)....
Angiotensin-converting enzyme inhibitors (ACE-I), such as lisinopril, are used as first-line therapy in the treatment of hypertension, heart failure with reduced ejection fraction, and proteinuric chr...
Lisinopril is commonly prescribed to manage conditions such as hypertension and heart failure. While concerns about fetal toxicity have traditionally limited the use of lisinopril in women of reproduc...
Based on a clinical case report, the article shows the individual selection of effective therapy for a patient with arterial hypertension and dyslipidemia. Taking into account the risk factors for car...
Both lisinopril and enalapril are angiotensin-converting enzyme (ACE) drugs and widely used in the treatment of hypertension. Enalapril does not cross the blood-brain barrier, but lisinopril is centra...